EFFECT OF ANTI-PD-1 THERAPY COMBINATION ON TEMOZOLOMIDE IN MOUSE GLIOBLASTOMA

被引：0
|
作者：
Park, Junseong [1 ]
Kim, Chang Gon [2 ]
Shim, Jin-Kyong [3 ]
Lee, Jae Eun [1 ]
Chang, Jong Hee [2 ]
Shin, Eui-Cheol [2 ]
Kang, Seok-Gu [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurosurg,Brain Tumor Ctr, Seoul, South Korea
[2] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Deajeon, South Korea
[3] Severance Hosp, Seoul, South Korea
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-16
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
    Park, Junseong
    Kim, Chang Gon
    Shim, Jin-Kyoung
    Kim, Jong Hoon
    Lee, Hoyoung
    Lee, Jae Eun
    Kim, Min Hwan
    Haam, Keeok
    Jung, Inkyung
    Park, Su-Hyung
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    [J]. ONCOIMMUNOLOGY, 2019, 8 (01):
  • [2] EFFECT OF COMBINED ANTI-PD-1 AND TEMOZOLOMIDE THERAPY IN GLIOBLASTOMA
    Park, Junseong
    Kim, Chang Gon
    Lee, Jae Eun
    Shim, Jin-Kyoung
    Kim, Eui Hyun
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    [J]. NEURO-ONCOLOGY, 2018, 20 : 123 - 124
  • [3] Anti-PD-1, anti-VEGF, and temozolomide therapy in a patient with recurrent glioblastoma: a case report
    Chen, Can
    Zuo, Wenwei
    Yang, Pan
    Zhang, Yanling
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (09)
  • [4] Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma
    Choi, John
    Medikonda, Ravi
    Saleh, Laura
    Kim, Timothy
    Pant, Ayush
    Srivastava, Siddhartha
    Kim, Young-Hoon
    Jackson, Christina
    Tong, Luqing
    Routkevitch, Denis
    Jackson, Christopher
    Mathios, Dimitrios
    Zhao, Tianna
    Cho, Hyerim
    Brem, Henry
    Lim, Michael
    [J]. ONCOIMMUNOLOGY, 2021, 10 (01):
  • [5] Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1
    Robert, Caroline
    Lebbe, Celeste
    Lesimple, Thierry
    Lundstrom, Eija
    Nicolas, Valerie
    Gavillet, Bruno
    Crompton, Philippa
    Baroudjian, Barouyr
    Routier, Emilie
    Lejeune, Ferdy J.
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (05) : 858 - 865
  • [6] Combination Therapy With Anti-PD-1 and Anti-B- and T-lymphocyte attenuator Results in a Synergistic Therapeutic Effect Against Murine Glioblastoma
    Choi, John
    Saleh, Laura
    Pant, Ayush
    Routkevitch, Denis
    Tong, Luqing
    Kim, Young-Hoon
    Xia, Yuanxuan
    Jackson, Christopher Mitchell
    Jackson, Christina
    Lim, Michael
    [J]. NEUROSURGERY, 2019, 66 : 74 - 75
  • [7] COMBINING ANTI-PD-1 IMMUNOTHERAPY WITH STEREOTACTIC RADIOSURGERY IN A MOUSE ORTHOTOPIC GLIOBLASTOMA MODEL
    Zeng, J.
    See, A.
    Phallen, J.
    Belcaid, Z.
    Durham, N.
    Meyer, C.
    Pradilla, G.
    Ford, E.
    Wong, J.
    Hammers, H.
    Tyler, B.
    Brem, H.
    Tran, P.
    Pardoll, D.
    Lim, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 102 : S34 - S34
  • [8] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [9] Anti-PD-1 therapy in the frontline
    David Killock
    [J]. Nature Reviews Clinical Oncology, 2016, 13 (12) : 715 - 715
  • [10] Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
    Mitchell, Dana
    Dey, Mahua
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S577 - S579
12345